0000899243-20-028931.txt : 20201021 0000899243-20-028931.hdr.sgml : 20201021 20201021210809 ACCESSION NUMBER: 0000899243-20-028931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201019 FILED AS OF DATE: 20201021 DATE AS OF CHANGE: 20201021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swisher Daniel N JR CENTRAL INDEX KEY: 0001323113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 201251466 MAIL ADDRESS: STREET 1: C/O SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-19 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001323113 Swisher Daniel N JR C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Common Stock 2020-10-19 4 M 0 5000 6.55 A 5000 D Common Stock 2020-10-19 4 S 0 5000 17.6602 D 0 D Stock Option (Right to Buy) 6.55 2020-10-19 4 M 0 5000 0.00 D 2025-06-18 Common Stock 5000 55000 D The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $17.51 to $17.96 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request. Fully exercisable. /s/ Charles Robb, Attorney-in-Fact for Daniel N. Swisher, Jr. 2020-10-21